ATHERSYS, INC / NEW
DelistedCIK 1368148fmd_0BZVQY76KKAZSSY4V2EBNDP3JZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2023, 55 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 2 | 12 | 17 | 4 | 24 | 6 | 1 | 6 | 5 |
| Net interest income | – | – | – | – | – | – | – | – | – | – |
| Research and development | 20 | 23 | 21 | 25 | 28 | 39 | 39 | 63 | 71 | 65 |
| Operating income | (24) | (29) | (17) | (15) | (33) | (25) | (45) | (78) | (87) | (77) |
| Other non-operating income (expense) | 0 | 0 | (0) | 0 | 0 | 1 | 1 | (0) | 0 | 0 |
| Income before taxes | (31) | (22) | (16) | (15) | (32) | (24) | – | – | – | – |
| Income tax expense | – | (0) | (0) | (0) | 0 | 0 | – | – | – | – |
| Net income from continuing operations | – | (22) | (16) | (15) | (32) | (24) | – | – | – | – |
| Net income | (31) | (22) | (16) | (15) | (32) | (24) | (45) | (79) | (87) | (73) |
| Net income to common shareholders | (31) | (24) | (17) | (15) | (32) | – | – | – | – | – |